Digital Oncology Market
Every Market-Reports.com study delivers in-depth market sizing, growth forecasts, competitive intelligence, segmentation analysis, and regional insights — built from company filings, government statistics and trade data, and structured for confident strategic decision-making. Request a free report preview to see its scope, chapters and methodology before you buy.
Market Snapshot
2025 Market Size
US$ 3.6 billion
Estimated Base Value
2035 Forecast
US$ 13.6 billion
Projected Market Value
CAGR 2026–2035
14.2%
Compound Annual Growth
Largest Segment
Digital Therapeutics for Oncology
Fastest Growing Segment
Electric Commercial Vehicles
Leading Region
North America
Fastest Growing Region
Asia Pacific
Top Country
United States
By Market Share
Largest market
Key Players
Tempus
Emerging Players
Paige, Guardant Health
Digital Oncology Market Overview
The Digital Oncology Market utilizes advanced digital technologies to enhance various stages of cancer care, primarily within the pharmaceutical and biotechnology industries. This market includes software platforms, artificial intelligence and machine learning tools, data analytics solutions, and remote monitoring services. These are specifically designed for oncology drug discovery, clinical trial management, patient engagement, personalized treatment strategies, and real-world evidence generation. The goal is to accelerate therapeutic development, improve patient outcomes through data-driven insights, and streamline the delivery and monitoring of cancer treatments.
The Digital Oncology Market is estimated at $3.6 Bn in 2025 and is forecast to reach $13.6 Bn by 2035, exhibiting a compound annual growth rate (CAGR) of 14.2% from 2025 to 2035. Demand is driven by rising global cancer incidence and technological advancements in AI, data analytics, and connectivity. Increased patient engagement and favorable regulatory support also contribute to growth. However, data privacy concerns, high initial investment costs, and regulatory complexities act as restraints.
The market is segmented by Type (Digital Therapeutics for Oncology, Teleoncology Platforms, Oncology Data Analytics & Artificial Intelligence Platforms, Remote Patient Monitoring Solutions for Oncology, Digital Health Apps for Cancer Management, Electronic Health Records & Oncology-Specific Emrs, Clinical Trial Management Systems for Oncology, Precision Oncology Platforms), Application, Technology, End-User, Component, and Mode. Geographically, it is served across North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Leading companies include Tempus, ConcertAI, Caris Life Sciences, Sophia Genetics, PathAI, Owkin, Freenome, Natera, Myriad Genetics, C2i Genomics, Fabric Genomics, and In Silico Medicine. The full report provides comprehensive coverage of these segments and regional analyses.
Market Definition & Overview
The Digital Oncology Market leverages advanced digital technologies to optimize and enhance various stages of cancer care, predominantly within the pharmaceutical and biotech industries. This market encompasses software platforms, AI/ML tools, data analytics solutions, and remote monitoring services specifically designed for oncology drug discovery, clinical trial management, patient engagement, personalized treatment strategies, and real-world evidence generation. It aims to accelerate therapeutic development, improve patient outcomes through data-driven insights, and streamline the delivery and monitoring of cancer treatments, fostering a more connected and efficient oncology ecosystem. This market integrates digital innovations to revolutionize how cancer pharmaceuticals are researched, developed, prescribed, and managed.
Scope
- Global market coverage across all major regions.
- Analysis of software, services, and integrated digital platforms.
- Market forecast and trend analysis from 2025 to 2035.
- Segmentation by application area within the pharmaceutical oncology value chain.
Inclusions
- Digital therapeutics (DTx) for oncology patient support and adherence.
- AI and machine learning platforms for oncology drug discovery and development.
- Cloud-based solutions for oncology clinical trial management and data analysis.
- Telehealth and remote patient monitoring systems specific to cancer care.
- Real-world evidence (RWE) and data analytics platforms for oncology pharmaceuticals.
- Oncology-specific patient engagement and education digital tools.
Exclusions
- General healthcare IT solutions not specialized for oncology.
- Traditional pharmaceutical manufacturing equipment and processes.
- Medical devices and diagnostics lacking specific digital oncology integration.
- Direct in-person clinical services not enabled by digital platforms.
- Digital solutions targeting non-oncology disease areas.
Market Size Forecast
Executive Summary
• The Digital Oncology market is valued at $3.6 Bn in 2025 and is forecast to reach $13.6 Bn by 2035, reflecting a robust CAGR of 14.2% as demand accelerates across every major segment and region over the ten-year outlook.
• Digital Therapeutics for Oncology leads the segment breakdown by current market share, underscoring where the bulk of near-term revenue and competitive activity within this market is concentrated today.
• North America commands the largest regional share at XX.X%, while Emerging Areas is expanding the fastest at a XX.X% CAGR, signalling where future growth is shifting.
• United States remains the single largest country-level market at XX.X% of global share, anchoring overall demand within its home region throughout the forecast period.
• Consolidation by pharmaceutical giants and tech firms is accelerating, driven by synergistic data integration needs and value chain control, profoundly reshaping the competitive landscape globally.
• AI and RWD integration are propelling precision oncology, democratizing access to specialized care, and fundamentally redefining patient-centric treatment pathways across diverse global healthcare systems.
• Evolving regulatory frameworks for data interoperability and AI-driven diagnostics are pivotal, fostering innovation while demanding robust, adaptive compliance strategies from market participants globally.
• Regional disparities in digital health infrastructure and regulatory maturity necessitate tailored market entry strategies, particularly balancing innovation adoption in developed versus emerging economies.
• Strategic partnerships between pharmaceutical innovators and technology providers are crucial, optimizing value chain efficiencies and driving targeted investment into scalable, integrated digital solutions.
• The market’s forward trajectory hinges on successful integration of predictive analytics and virtual care, promising a transformative shift towards proactive, preventive, and highly personalized oncology management.
Key Market Takeaways
Critical findings and data points from this market research study.
Current Market Valuation
The Digital Oncology market was valued at $3.6 billion in the base year, reflecting its significant initial footprint.
Future Market Expansion
The market is projected to reach an impressive $13.6 billion by the forecast year, indicating substantial growth potential.
Robust Growth Outlook
The Digital Oncology market is anticipated to grow at a Compound Annual Growth Rate (CAGR) of 14.2% over the forecast period.
Exponential Market Growth
From a base value of $3.6 billion, the Digital Oncology market is set for exponential growth at a CAGR of 14.2%, reaching $13.6 billion by the forecast year.
Regional Leadership
North America is anticipated to hold a dominant share in the digital oncology market, driven by advanced infrastructure and high adoption rates.
AI-Powered Solutions
Artificial intelligence and machine learning solutions are expected to emerge as a leading segment, enhancing precision and efficiency in oncology care.
Market Dynamics
Market Trends
- Increased adoption of AI and machine learning in oncology.
- Growing focus on remote patient monitoring and telehealth.
- Integration of real-world data for personalized treatments.
- Expansion of digital therapeutics for cancer management.
Growth Drivers
- Rising global cancer incidence fuels demand for solutions.
- Technological advancements in AI, data analytics, and connectivity.
- Increased patient engagement and demand for personalized care.
- Favorable regulatory support for digital health solutions.
Restraints
- Data privacy concerns impede widespread adoption of digital solutions.
- High initial investment costs challenge market entry and expansion.
- Regulatory complexities slow down product development and market access.
- Integration difficulties with existing healthcare IT systems persist.
Opportunities
- Developing predictive analytics tools for early cancer detection.
- Expanding into emerging markets with high unmet needs.
- Partnerships with pharma for drug development and diagnostics.
- Innovating digital platforms for comprehensive cancer care.
Market Dynamics Framework · 2026–2035
Need Custom Data for This Market?
Get tailored segmentation, deeper competitive intelligence, or region-specific deep dives from our analyst team.
Market Segmentation
| Segment | Sub-segments |
|---|---|
| By Type | Digital Therapeutics for OncologyTeleoncology PlatformsOncology Data Analytics & Artificial Intelligence PlatformsRemote Patient Monitoring Solutions for OncologyDigital Health Apps for Cancer ManagementElectronic Health Records & Oncology-Specific EmrsClinical Trial Management Systems for OncologyPrecision Oncology Platforms |
| By Application | Diagnosis & ScreeningTreatment Planning & DeliveryPatient Monitoring & Follow-UpDrug Discovery & DevelopmentClinical Trials ManagementSymptom Management & Supportive CareGenomic Profiling & Precision MedicinePatient Engagement & Education |
| By Technology | Artificial Intelligence & Machine LearningBig Data AnalyticsCloud ComputingInternet of Medical ThingsTelemedicine & Virtual Care InfrastructureGenomic Sequencing & BioinformaticsAugmented Reality & Virtual RealityBlockchain |
| By End-User | Hospitals & Oncology ClinicsPharmaceutical & Biotechnology CompaniesAcademic & Research InstitutionsContract Research OrganizationsPatients & CaregiversPayers & Healthcare ProvidersGovernment Agencies & Public Health Organizations |
| By Component | SoftwareServicesHardwareData Repositories & Databases |
| By Mode | SubscriptionPay-Per-UsePerpetual LicenseValue-Based Payment & Risk-SharingFreemium & Ad-Supported |
Regional Analysis
- North America leads the digital oncology market, driven by substantial healthcare investments, rapid adoption of advanced digital health technologies, and a robust presence of key pharmaceutical and tech companies. High patient awareness and supportive regulatory frameworks also contribute significantly to its dominance.
- Asia-Pacific is the fastest-growing digital oncology market. This surge is driven by increasing cancer incidence, improving healthcare infrastructure, and rising digital literacy. Government initiatives promoting digital health and growing demand for accessible, efficient cancer care solutions are key contributors.
- Europe exhibits a noteworthy trend towards integrating AI-driven personalized medicine solutions into digital oncology. Countries are focusing on developing sophisticated systems for tailored treatments, optimizing drug discovery, and enhancing patient monitoring. Strong emphasis is placed on data privacy and interoperability across diverse healthcare frameworks.
| North AmericaXX.X% | EuropeXX.X% | Asia PacificXX.X% | Latin AmericaXX.X% | Middle East & AfricaXX.X% |
North America
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- Dominates the market due to robust healthcare infrastructure, high adoption of advanced digital health technologies, and significant investment in oncology R&D and patient care solutions.
- The presence of key industry players and strong regulatory support further fuels its leadership.
Latin America
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- A developing market with significant potential, fueled by improving internet penetration, growing demand for accessible healthcare, and increasing awareness of digital health benefits.
- Economic disparities and varying levels of healthcare infrastructure across countries pose challenges.
Europe
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- A mature market characterized by sophisticated healthcare systems, increasing integration of digital tools in oncology pathways, and government initiatives promoting e-health.
- However, fragmented regulatory landscapes across member states can present some adoption challenges.
Asia Pacific
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- Experiencing rapid growth driven by rising cancer incidence, increasing healthcare expenditure, and a burgeoning tech-savvy population.
- Countries like China, India, and Japan are investing heavily in digital health infrastructure and remote care solutions to address vast patient populations.
Middle East & Africa
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- Showing considerable growth, particularly in technologically advanced GCC countries investing in smart healthcare initiatives and medical tourism.
- Other parts of Africa are seeing nascent adoption, driven by mobile health solutions addressing infrastructure limitations and improving patient access.
Country Analysis
United States and Brazil represent the largest country-level markets, with growth across the remaining countries shaped by local regulatory, infrastructure, and demand-side factors specific to each geography.
| # | Country | Market Size | CAGR | Key Driver |
|---|---|---|---|---|
| 1 | United States | US$ XX.X Mn | XX.X% | The United States holds the largest share due to its massive healthcare spending, advanced technological infrastructure, and extensive research and development in oncology solutions. High adoption rates of precision medicine and telehealth further drive market growth. |
| 2 | Brazil | US$ XX.X Mn | XX.X% | As the largest economy in South America, Brazil presents significant growth potential with increasing investment in healthcare IT and a vast patient population driving demand for digital oncology solutions and telehealth services. |
| 3 | Germany | US$ XX.X Mn | XX.X% | Germany's robust economy, advanced healthcare system, and proactive adoption of digital health initiatives, including strong data privacy frameworks, position it as a key market for digital oncology solutions and precision medicine. |
| 4 | China | US$ XX.X Mn | XX.X% | China is a dominant market driven by massive patient volumes, rapid digitalization across healthcare, and substantial government investment in AI, big data, and digital platforms for oncology diagnosis and treatment. |
| 5 | Saudi Arabia | US$ XX.X Mn | XX.X% | Saudi Arabia's significant government investment in healthcare infrastructure and digitalization under Vision 2030, including specialized oncology centers, drives rapid adoption of digital solutions for cancer care delivery. |
Countries Covered (26)
United States, Canada, Mexico, Brazil, Argentina, Rest of Latin America, Germany, United Kingdom, France, Spain, Italy, Russia, Rest of Europe, China, Japan, India, South Korea, Australia, Taiwan, Singapore, Malaysia, Rest of Asia Pacific, Saudi Arabia, United Arab Emirates, South Africa, Rest of Middle East & Africa
Competitive Landscape
| # | Company | Share | Key Strategy | Key Note | Key Developments | Key Products |
|---|---|---|---|---|---|---|
| 1 | Tempus | XX.X% | Leverage AI-powered platforms and proprietary molecular and clinical data to provide precision medicine solutions for oncology. | — | — | Tempus xTTempus xETempus xF+1 |
| 2 | ConcertAI | XX.X% | Apply AI and real-world data (RWD) solutions to accelerate clinical research and improve patient outcomes in oncology. | — | — | eureka rwd360eureka rwe360eureka clinops360+1 |
| 3 | Caris Life Sciences | XX.X% | Provide comprehensive molecular profiling services to guide precision oncology treatment decisions and accelerate drug development. | — | — | Caris Molecular IntelligenceMI ProfileMI Exome+1 |
| 4 | Sophia Genetics | XX.X% | Empower healthcare institutions globally with a universal platform for data-driven medicine, leveraging AI for genomic and multimodal data analysis. | — | — | SOPHiA DDM PlatformSOPHiA AICARE Platform+1 |
| 5 | PathAI | XX.X% | Accelerate medical innovation and improve patient care through AI-powered pathology solutions, focusing on diagnostics and drug development. | — | — | PathAI PlatformAISightAIM-L+1 |
Market Positioning Map
Market share vs. growth outlook — bubble size is market share, bubble color is relative profitability
Companies Profiled (20)
Tempus, ConcertAI, Caris Life Sciences, Sophia Genetics, PathAI, Owkin, Freenome, Natera, Myriad Genetics, C2i Genomics, Fabric Genomics, In Silico Medicine, BenevolentAI, CureMatch, Onc.AI, Deep Bio, Volpara Health Technologies, Quantgene, Imagia Cybernetics, Mindpeak
The global Digital Oncology market features a competitive landscape led by Tempus, ConcertAI, Caris Life Sciences, Sophia Genetics, PathAI, and Owkin, among other established and emerging players. Market participants continue to compete on product innovation, pricing strategy, geographic expansion, and strategic partnerships to strengthen their position in this evolving market.
* Market share estimates based on company revenue disclosures and public sources; undisclosed figures are marked.
Company Profiles
Tempus
ConcertAI
Caris Life Sciences
Sophia Genetics
PathAI
Owkin
Freenome
Natera
Myriad Genetics
C2i Genomics
Fabric Genomics
In Silico Medicine
BenevolentAI
CureMatch
Onc.AI
Deep Bio
Volpara Health Technologies
Quantgene
Imagia Cybernetics
Mindpeak
* Classification reflects relative market share and maturity, derived from revenue analysis and public disclosures.
Ready to Make Data-Driven Decisions?
Purchase the full report or request a custom engagement. Get analyst support, scenario modelling, and real-time dashboard access.
Recent Market Developments
OncoAI Unveils Precision Cancer Treatment Platform
OncoAI, a leader in AI healthcare solutions, has launched its new 'CuraPlan AI' platform, designed to analyze vast genomic and clinical data to recommend highly personalized cancer treatment protocols and predict patient responses. This aims to revolutionize treatment selection and improve patient outcomes.
Pharma Giant Acquires Digital Therapeutics Innovator
Global pharmaceutical powerhouse, MedPharma Corp., announced its acquisition of DigiThera Oncology, a pioneer in prescription digital therapeutics for managing chemotherapy side effects and improving adherence. The move integrates digital patient support into MedPharma's oncology portfolio, enhancing patient care beyond traditional drugs.
Major Research Center Partners for Real-World Evidence in Oncology
The National Cancer Institute (NCI) has forged a strategic partnership with HealthData Analytics, a leading big data firm, to develop a comprehensive real-world evidence (RWE) platform. This collaboration aims to leverage diverse patient data sets to accelerate insights into cancer treatment effectiveness and long-term outcomes, informing future research and clinical guidelines.
Remote Cancer Care Platform Secures US$ XX.X Series B Funding
OncoConnect, a rapidly growing platform for remote patient monitoring and virtual supportive care in oncology, successfully closed a US$ XX.X Series B funding round led by HealthTech Ventures. The investment will fuel expansion into new markets and further development of its AI-driven predictive analytics for early intervention in complications.
Report Data Parameters
| Parameter | Value |
|---|---|
| Base Year | 2025 |
| Forecast Year | 2035 |
| Historical Period | 2019–2025 |
| Market Size (Base Year) | $3.6 Bn |
| Market Size (Forecast) | $13.6 Bn |
| CAGR | 14.2% |
| Forecast Period | 2026–2035 |
| Geography | Global |
| Countries Covered | 26 Countries |
| Segments Covered | 6 Segments, 40 Sub-segments |
| Companies Profiled | 32 Companies |
Report Value
Why Choose This Report
Complete Market Size
Market sizing for the base year and a 10-year forecast across three scenarios.
Segment Analysis
Deep-dive segmentation by product, application, end-user, and technology verticals.
Country Analysis
Country-level market data for every country in the report scope, across all major regions.
Company Profiles
Profiles of the leading companies, with disclosed financials, strategy and market share.
Market Share
Detailed competitive market share analysis with trend mapping and benchmarking.
Competitive Intelligence
SWOT, Porter's Five Forces, and competitive positioning across market leaders.
Scenario Analysis
Three-scenario modelling (Base / Optimistic / Conservative) with CAGR decomposition.
Regulatory Review
Regulatory landscape, compliance requirements, and policy impact analysis by region.
Strategic Analysis · Management Insights · CXO Insights
Executive Strategic & Intelligence Report
A board-ready strategic deck built on the Digital Oncology Market report: eleven chapters and an appendix, from market sizing to the board decisions, delivered as a PDF with an Excel datapack. US$3,000 per market, prepared after your order.
What to expect in the Executive Report for this market
- About 400 slides, 11 chapters and an appendix. Built on this report's own numbers, so every figure matches the report and the Excel.
- Market size and forecast to 2035. By segment, sub-segment, region and country, with conservative, base and optimistic cases.
- An analysis page after every exhibit. The key insight, ten specific points and the decision it implies for leaders, challengers, entrants and investors.
- Competitive intelligence. Shares and positioning, capability benchmark, strategies, recent moves and acquisition screening.
- Customers, technology and business models. Who buys and why, AI and technology impact, pricing, channels and go-to-market by segment.
- Risks and scenarios. Risk register, four future scenarios with signposts, and early-warning indicators with thresholds.
- Opportunities and the board decisions. Opportunity scoring, strategic options, roadmap, capability gaps, decision matrix and a 90-day plan.
- PDF, Excel datapack and PowerPoint. A bookmarked PDF, the full Excel datapack and editable infographic slides for your own decks.
US$3,000 per market · bought online, prepared after your order and emailed to you
See a full example report →Only need the headline view? Market Snapshot (PDF) + Excel Datasheet · 10–20 slide PDF + Excel
A CEO-level executive summary of the market in 10–20 slides - size and forecast, growth by segment and region, the leading countries and companies, key trends and the outlook - plus the Excel datasheet. A short executive view of this market, not the full analysis - PDF and Excel, prepared and emailed to you after your order.
Trusted by strategy teams, investors & global enterprises
What Our Clients Say
Verified reviews from enterprise clients
“The depth of analysis and quality of data is unparalleled. This report directly informed our $50M market expansion strategy and helped us prioritise the right geographies.”
Sarah Chen
VP Strategy, Fortune 500 Manufacturer
“Exceptional research quality. The competitive landscape section alone saved our team months of primary research effort and gave us a clear view of the opportunity.”
Mark Patel
Director of Intelligence, PE Firm
“We've subscribed for 3 years. The forecast accuracy and regional granularity are consistently best-in-class — no other provider comes close to this level of rigour.”
Lena Hoffmann
Head of Market Intelligence, Industrial MNC
Frequently Asked Questions
Common questions about this report and our research
The Digital Oncology market is estimated at $3.6 Bn in 2025. It is forecast to reach $13.6 Bn by 2035, indicating substantial expansion over the forecast period.
The Digital Oncology market is forecast to grow at a compound annual growth rate (CAGR) of 14.2% from 2025 to 2035. This growth reflects increasing adoption of digital solutions in cancer care.
The main segments include Digital Therapeutics for Oncology, Teleoncology Platforms, Oncology Data Analytics & Artificial Intelligence Platforms, Remote Patient Monitoring Solutions for Oncology, and Digital Health Apps for Cancer Management. Other segments cover Electronic Health Records, Clinical Trial Management Systems, and Precision Oncology Platforms.
Leading companies in the Digital Oncology market include Tempus, ConcertAI, Caris Life Sciences, Sophia Genetics, PathAI, Owkin, Freenome, Natera, Myriad Genetics, C2i Genomics, Fabric Genomics, and In Silico Medicine. These companies offer various digital solutions for oncology.
The Digital Oncology market report covers market size and growth forecasts, detailed segmentation by Type, Application, Technology, End-User, Component, and Mode. It also includes regional analysis across major geographies and profiles of leading companies in the market.
The Single User and Enterprise licences include the full PDF report, the PowerPoint (PPT), the Excel data workbook and the interactive Online Dashboard. The Online Dashboard gives online access to the snapshot and datasheet with export features, and the Market Snapshot is an executive summary in PDF with the Excel data sheet.
Yes. Request a free report preview: its scope, every chapter and what it contains, the methodology and the headline figures. The full report is a paid product.
We accept credit/debit cards (Visa, Mastercard, Amex), bank wire transfer, and purchase orders for enterprise clients. All transactions are secured with 256-bit SSL encryption.
Buy This Report
Choose the format that fits your budget
Digital delivery — all sales are final. See our Refund Policy and Terms & Conditions.
Strategic deck for this market
Executive Strategic & Intelligence Report
About 400 board-ready slides: every exhibit with its analysis and the decision it implies. Prepared for this market after your order and emailed to you.
Need to go deeper?
Intelligence services for this market
- Competitor benchmarking →
- Market entry & expansion →
- Product & growth opportunities →
- Investment & acquisition due diligence →
What's Included
Similar Reports
Bioprocess Digital Twin Market
$512.0 Mn in 2025 · 24.0% CAGR
Bioproduction Digital Twin Market
$214.0 Mn in 2025 · 24.4% CAGR
Biotechnology Digital Twins Market
$338.0 Mn in 2025 · 24.0% CAGR
Digital Biobank Market
$436.0 Mn in 2025 · 14.6% CAGR
Digital Biology Market
$4.3 Bn in 2025 · 21.6% CAGR
Digital Biomarker Platform Market
$612.0 Mn in 2025 · 20.3% CAGR
Digital Biopharmaceutical Market
$5.0 Bn in 2025 · 18.9% CAGR
Digital Bioprocess Automation Market
$1.7 Bn in 2025 · 15.7% CAGR